Ardelyx (ARDX) Interest Coverage Ratio (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -761.50% |
| Dec 31, 2025 | 9.93% |
| Sep 30, 2025 | 124.37% |
| Jun 30, 2025 | 61.90% |
| Mar 31, 2025 | -523.46% |
| Dec 31, 2024 | 207.91% |
| Sep 30, 2024 | 116.23% |
| Jun 30, 2024 | 60.88% |
| Mar 31, 2024 | 34.88% |
| Dec 31, 2023 | -340.67% |
| Sep 30, 2023 | 143.22% |
| Jun 30, 2023 | 39.01% |
| Mar 31, 2023 | -306.92% |
| Dec 31, 2022 | 149.62% |
| Sep 30, 2022 | 26.80% |
| Jun 30, 2022 | 9.49% |
| Mar 31, 2022 | -3.98% |
| Dec 31, 2021 | -3.20% |
| Sep 30, 2021 | 6.88% |
| Jun 30, 2021 | -28.19% |
| Mar 31, 2021 | -38.30% |
| Dec 31, 2020 | -47.35% |
| Sep 30, 2020 | 27.69% |
| Jun 30, 2020 | -23.08% |
| Mar 31, 2020 | -18.99% |
| Dec 31, 2019 | 11.93% |
| Sep 30, 2019 | 10.54% |
| Jun 30, 2019 | 3.77% |
| Mar 31, 2019 | 6.60% |
| Dec 31, 2018 | -12.63% |
| Sep 30, 2018 | 47.20% |
| Sep 30, 2014 | -96.63% |
| Sep 30, 2013 | 67.97% |